AstraZeneca-BioNTech jab combo safe, effective - study

Tuesday, 18. May 2021 16:35

Combined doses of COVID-19 vaccines developed by AstraZeneca plc and BioNTech SE have been confirmed to be safe and effective, according to the preliminary results published by Spain's Carlos III Health Institute on Tuesday.

The research revealed that the level of antibodies present in people vaccinated with one AstraZeneca dose and one BioNTech dose is between 30 and 40 times larger compared to the one seen after the two-dose vaccine from AstraZeneca.

The study comes as numerous health authorities across the globe decided to switch the second AstraZeneca vaccine dose with another mRNA vaccine due to concerns of blood clots which have led to death in rare cases. Other mRNA jabs include those manufactured by Pfizer, BioNTech as well as Moderna.

Related Links: BioNTech SEAstraZeneca plc
Author:
Breaking the News / ND